Effects of the psychedelic amphetamine MDA (3,4-Methylenedioxyamphetamine) in healthy volunteers

M. J. BAGGOTT ; K. J. GARRISON ; J. R. COYLE ; G. P. GALLOWAY ; A. J. BARNES ; M. A. HUESTIS ; J. E. MENDELSON | 2019
Dans Journal of Psychoactive Drugs (Vol.51, n°2, April-June 2019) Article : Périodique

Entactogens such as 3,4-Methylenedioxymethamphetamine (MDMA, "molly", "ecstasy") appear to have unusual, potentially therapeutic, emotional effects. Understanding their mechanisms can benefit from clinical experiments with related drugs. Yet the[...]

Plus d'info

Ajouter à la sélection

Preventing problems in ecstasy users: reduce use to reduce harms

M. J. BAGGOTT | 2002
Périodique

ENGLISH : Increasing use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been accompanied by concern about acute and possible long-term toxicity. This article discusses acute serious toxicity, chronic toxicity, and common problems a[...]

Plus d'info

Ajouter à la sélection

Use patterns and self-reported effects of Salvia divinorum: An internet-based survey

M. J. BAGGOTT ; E. EROWID ; F. EROWID ; G. P. GALLOWAY ; J. MENDELSON | 2010
Dans Drug and Alcohol Dependence (Vol.111, n°3, October 2010) Article : Périodique

Background: There is growing use of Salvia divinorum (SD), a psychoactive plant that produces hallucinogen-like effects through a kappa opioid receptor (KOR) mechanism. Little is known about KOR agonist effects in humans and about users of SD. [...]

Plus d'info

Ajouter à la sélection